SANSUM DIABETES RESEARCH INSTITUTE

As filed

Subsection

03

NTEE code

H05

Classification

8000

Street

2219 BATH ST

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2025

• ResearchClinical Research Type 1 DiabetesSansum Diabetes Research Institute (SDRI) is a nonprofit organization dedicated to improving the lives of people impacted by diabetes through clinical research, education, and specialized patient care. During 2025, SDRI initiated 13 clinical research trials involving 197 individual participants. These studies evaluated new technologies, medications, and treatment approaches intended to improve diabetes management and health outcomes.Research activities included automated insulin delivery systems, continuous glucose monitoring, inhaled insulin therapies, GLP-1 medications, ketone and lactate monitoring, digital health tools, and other emerging diabetes technologies. SDRI collaborated with leading diabetes technology and pharmaceutical companies to conduct research that supports the development of safer and more effective treatments for people living with diabetes.During 2025, SDRI also launched Screen & Support, a community-based type 1 diabetes early detection program. Through autoantibody screening, education, monitoring, and follow-up care, the program identifies children and adults at increased risk for developing type 1 diabetes before symptoms occur. Earlier identification helps reduce the likelihood of diagnosis during diabetic ketoacidosis (DKA), provides families with education and support, and expands access to therapies that may delay progression to insulin-dependent disease. SDRI also continued leading the California Type 1 Diabetes Screening Collaborative to expand early detection efforts throughout California.Clinical Research Type 2 DiabetesSDRI continued research designed to improve treatment options and clinical outcomes for individuals living with type 2 diabetes. During 2025, the SDRI participated in studies evaluating automated insulin delivery systems, continuous glucose monitoring technologies, and emerging therapeutic approaches intended to improve glycemic control while reducing the burden of diabetes management.Research findings contributed to the growing body of evidence supporting advanced diabetes technologies for adults with type 2 diabetes and included participation from diverse populations to improve the applicability of study findings across communities.

  Expenses $4,634,525 · Revenue $1,969,111

• Education and Community OutreachCommunity education is an essential component of SDRI's charitable mission. SDRI provides evidence-based education, peer support, and culturally responsive programs that improve diabetes prevention and self-management.During 2025, SDRI continued Ocho Pasos a la Buena Salud, a Spanish-language diabetes prevention and self-management program led by trained Community Health Workers (Promotoras). The program provides culturally appropriate education on nutrition, physical activity, and diabetes self-management while addressing barriers to healthcare access.SDRI also expanded education and support through One Talk, LADA Talk, diabetes technology training, bilingual support groups, community outreach events, and Back-to-School educational programming. These programs improve diabetes knowledge, increase self-management skills, reduce diabetes-related distress, and strengthen community support for individuals and families affected by diabetes.

  Expenses $367,818 · Revenue $68,073

• Clinical CareSDRI provides specialized outpatient clinical care in diabetes in pregnancy, pediatric diabetes, and adult endocrinology.During 2025, SDRI expanded its Diabetes in Pregnancy Program to preserve access to specialized care following changes in local maternal health services. SDRI assumed responsibility for caring for approximately 100 additional patients, with particular emphasis on serving under-resourced and underrepresented Latina women throughout Santa Barbara County.Clinical services include individualized diabetes management, nutrition counseling, continuous glucose monitoring support, medication management, diabetes education, and coordinated care with obstetric and maternal-fetal medicine providers. SDRI also provides culturally responsive and bilingual services to improve maternal and infant health outcomes.SDRI's pediatric diabetes program provides comprehensive education, technology training, behavioral support, and ongoing clinical care that helps children, adolescents, and families safely manage diabetes and successfully transition to lifelong self-management.

  Expenses $279,669 · Revenue $50,045

• Research InfrastructureDuring 2025, SDRI completed renovation of its 18,000-square-foot research, clinical care, and education center. The renovated facility increased organizational capacity by providing dedicated research suites, expanded clinical space, industry collaboration areas, a teaching kitchen, a DEXA research suite, and community education facilities. These improvements enhance SDRI's ability to conduct clinical research, provide specialized patient care, and deliver diabetes education programs that benefit the community.Summary of Public BenefitThrough its integrated programs in clinical research, specialized clinical care, early detection, education, and community outreach, SDRI advances the early detection, treatment, and management of diabetes while improving access to evidence-based care for children, adults, pregnant individuals, and underserved populations. These activities further SDRIs charitable mission by improving health outcomes, expanding access to specialized services, and advancing diabetes science for the benefit of the public.

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2025

As listed in Part VII of the 2025 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

The first 25 listed. Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

• 2025

  Revenue

  $6,303,337

  Expenses

  $7,162,681

  Contributions

  $2,934,028

  Grants paid

  $0

• 2023

  Revenue

  $10,639,114

  Expenses

  $6,651,715

  Contributions

  $6,445,750

  Grants paid

  $0

• 2023

  Revenue

  $10,639,114

  Expenses

  $6,651,715

  Contributions

  $6,445,750

  Grants paid

  $0

• 2022

  Revenue

  $8,154,412

  Expenses

  $5,669,158

  Contributions

  $5,265,574

  Grants paid

  $0

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2021 · 990

  Revenue

  $11,475,472

  Expenses

  $5,271,529

  Assets (EOY)

  $20,925,060

• 2020 · 990

  Revenue

  $6,046,700

  Expenses

  $4,699,534

  Assets (EOY)

  $17,971,488

• 2019 · 990

  Revenue

  $4,170,902

  Expenses

  $5,138,512

  Assets (EOY)

  $15,270,515

• 2019 · 990

  Revenue

  $4,170,902

  Expenses

  $5,138,512

  Assets (EOY)

  $15,270,515

• 2018 · 990

  Revenue

  $4,284,862

  Expenses

  $4,858,981

  Assets (EOY)

  $14,944,833

• 2018 · 990

  Revenue

  $4,284,862

  Expenses

  $4,858,981

  Assets (EOY)

  $14,944,833

• 2018 · 990

  Revenue

  $4,284,862

  Expenses

  $4,858,981

  Assets (EOY)

  $14,944,833

• 2018 · 990

  Revenue

  $4,284,862

  Expenses

  $4,858,981

  Assets (EOY)

  $14,944,833

• 2016 · 990

  Revenue

  $3,146,634

  Expenses

  $3,554,163

  Assets (EOY)

  $13,379,944

• 2015 · 990

  Revenue

  $3,646,302

  Expenses

  $3,798,215

  Assets (EOY)

  $13,633,395

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.

Grants made

No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.

Grants received

• DONOR ADVISED CHARITABLE GIVING

  $302,121

  2022 · HEALTH

• DONOR ADVISED CHARITABLE GIVING

  $280,000

  2024 · HEALTH

• SILICON VALLEY COMMUNITY FOUNDATION

  $210,000

  2024 · Health

• SANTA BARBARA FOUNDATION

  $196,041

  2022 · MEDICAL RESEARCH

• ALLIANCE FOR POTATO RESEARCH AND EDUCATION

  $175,000

  2022 · RESEARCH GRANT

• FIDELITY INVESTMENTS CHARITABLE GIFT FUND

  $155,825

  2023 · For grant recipient's exempt purposes

• SANTA BARBARA FOUNDATION

  $152,231

  2024 · HEALTH CARE

• SANTA BARBARA FOUNDATION

  $146,000

  2023 · HEALTH CARE

• DONOR ADVISED CHARITABLE GIVING

  $139,300

  2023 · HEALTH

• FIDELITY INVESTMENTS CHARITABLE GIFT FUND

  $81,950

  2024 · For grant recipient's exempt purposes

The 10 largest by cash amount. The API serves every itemized grant.

Other IRS files